CI vs SUPN · P/E 2.4, rev $274.90B vs rev $661.8M
Cigna Corp (CI) versus Supernus Pharmaceuticals Inc (SUPN) — a side-by-side from cached financials, not a winner call.
Cigna Corp (CI) is a healthcare plans company listed on US.
Supernus Pharmaceuticals Inc (SUPN) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CI revenue for 2025-12-31 was $274.90B. Net income was $5.96B. Revenue was up 11.2% from 2024-12-31 to 2025-12-31. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Latest reported SUPN revenue for 2024-12-31 was $661.8M. Net income was $73.9M. Revenue was up 8.9% from 2023-12-31 to 2024-12-31. SUPN currently screens at market cap $2.53B.
CI currently screens at market cap $71.62B and trailing P/E 2.4. SUPN currently screens at market cap $2.53B.
Not investment advice. Open the CI and SUPN stock pages for the full models.
Not investment advice.